Figure 1: Effects of PIQE: high-precision T2-FSE imaging
Figure 1: Effects of PIQE: high-precision T2-FSE imaging
Figure 2: Fat-suppressed T2-FSE in a patient with hepatocellular carcinoma
Figure 2: Fat-suppressed T2-FSE in a patient with hepatocellular carcinoma
Figure 3: MRCP in a patient with suspected mixed IPMN
Figure 4: Dynamic imaging of fatty liver
Figure 4: Dynamic imaging of fatty liver
Figure 5: Dynamic imaging of hepatic hemangioma
Figure 5: Dynamic imaging of hepatic hemangioma
Figure 6: Dynamic imaging of hepatic metastases
Figure 7: Intrahepatic cholangiocarcinoma
Figure 7: Intrahepatic cholangiocarcinoma
Figure 8: Cancer in the uncinate process of the pancreas
The information on this website is not intended for consumers. It is directed exclusively for healthcare professionals and persons who are engaging in purchasing or the business of wholesaling therapeutic goods (in accordance with the Therapeutic Goods Advertising Code Instrument 2021).
By selecting “Continue” you are indicating that you are the intended audience. Click “Cancel” to be redirected to the Canon Medical Systems global website.
© Canon Medical Systems ANZ Pty Limited.
© Canon Medical Systems ANZ Pty Limited.